NYSE$GNW
Genworth Financial Inc · Q1 2022 earnings
Q1 2022 earnings · · Investor relations
Briefing
Genworth's financial performance showed a mixed outcome with net income decreasing, but strategic progress was made with debt reduction and share repurchase authorization.
Genworth Financial reported a net income of $149 million and adjusted operating income of $131 million for Q1 2022. The company announced a $350 million share repurchase authorization, marking their first shareholder return program in over 13 years. The U.S. Life Insurance segment experienced an adjusted operating loss, while Enact demonstrated strong performance.
- Net income was $149 million, or $0.29 per diluted share, compared to $187 million, or $0.37 per diluted share, in Q1 2021.
- Adjusted operating income was $131 million, or $0.25 per diluted share, compared to $168 million, or $0.33 per diluted share, in Q1 2021.
- Announced a $350 million share repurchase authorization, the first shareholder return program in over 13 years.
- Enact segment reported adjusted operating income of $135 million, with a 10% annual increase in insurance in-force and strong loss performance.
Headline financials
Revenue & EPS history
Genworth · Revenue · Quarterly
$1.89B
Forward guidance
Genworth's strategic plan aims to strengthen its financial position, maximize Enact Holdings' value, stabilize the legacy long-term care insurance block, advance long-term care growth initiatives, and return capital to shareholders. However, the company's ability to execute this plan is subject to various risks and constraints.
Tailwinds
- Potential for dividend payments from Enact Holdings.
- Possible improvements in business performance.
- Potential for reinsurance or similar transactions.
- Opportunities for asset sales, debt issuances, or securities offerings.
- Possible identification and contracting with a strategic partner regarding a new long-term care insurance business.
Headwinds
- Enact Holdings' ability to pay dividends may be restricted by GSEs' PMIERs requirements.
- Inability to increase capital needed in the company's businesses in a timely manner and on anticipated terms.
- Strategic priorities may change or become more costly or difficult to achieve.
- Inability to establish a new long-term care insurance business or product offerings due to commercial and/or regulatory challenges.
- Adverse tax or accounting charges, including new accounting guidance related to long-duration insurance contracts.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2022
-1.2%
Avg return
Earnings day
+0.5%
Avg return
5 days after
+3.1%
Avg return
30 days after
47%
34 / 72 earnings
Positive
+25.4%
Q2 2016
Best reaction
-37.7%
Q3 2014
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +3.4% | +2.1% | -2.5% | |
| Q4 2025 | +2.6% | +1.7% | +0.1% | |
| Q3 2025 | +0.2% | -0.9% | +1.1% | |
| Q1 2025 | -1.0% | +0.1% | +2.8% | |
| Q4 2024 | -7.9% | +1.0% | -9.0% | |
| Q3 2024 | +7.0% | +9.9% | +14.3% | |
| Q2 2024 | -3.2% | -9.5% | +2.5% | |
| Q1 2024 | +8.9% | +12.3% | +6.1% | |
| Q4 2023 | -2.8% | +0.0% | +2.8% | |
| Q3 2023 | -9.5% | -7.9% | +2.6% | |
| Q2 2023 | +0.8% | -3.1% | -10.5% | |
| Q1 2023 | -13.5% | -4.4% | +3.3% | |
| Q4 2022 | -5.2% | +3.0% | +6.6% | |
| Q3 2022 | +1.7% | -2.4% | +8.4% | |
| Q2 2022 | -1.6% | -0.7% | -0.7% | |
| Q1 2022 | +11.1% | +9.2% | +10.0% | |
| Q4 2021 | +1.5% | +1.3% | +3.6% | |
| Q3 2021 | -1.1% | -0.7% | -9.8% | |
| Q2 2021 | +0.6% | +7.5% | +11.3% | |
| Q1 2021 | -1.8% | -2.5% | -4.5% | |
| Q4 2020 | -18.2% | -20.2% | -15.3% | |
| Q3 2020 | +3.7% | +4.9% | +16.1% | |
| Q2 2020 | -13.7% | -12.0% | +1.7% | |
| Q1 2020 | -10.7% | -8.1% | -1.2% | |
| Q4 2019 | -3.2% | +18.2% | -7.6% | |
| Q3 2019 | +3.5% | +0.0% | -4.5% | |
| Q2 2019 | +2.3% | +1.0% | +14.6% | |
| Q1 2019 | -1.3% | +0.5% | -20.2% | |
| Q4 2018 | -1.9% | -4.4% | -21.2% | |
| Q3 2018 | +1.4% | -1.4% | +11.8% | |
| Q2 2018 | +1.7% | +0.0% | +1.3% | |
| Q1 2018 | +7.6% | +9.4% | +24.6% | |
| Q4 2017 | +2.8% | -4.2% | +5.9% | |
| Q3 2017 | +0.9% | +1.5% | +0.3% | |
| Q2 2017 | -1.5% | -0.3% | +0.0% | |
| Q1 2017 | +1.3% | +0.8% | -2.4% | |
| Q4 2016 | -3.1% | -2.0% | +13.7% | |
| Q3 2016 | -4.1% | -3.6% | -1.7% | |
| Q2 2016 | +25.4% | +24.6% | +68.2% | |
| Q1 2016 | +16.3% | — | — | |
| Q4 2015 | -12.1% | — | — | |
| Q3 2015 | -11.2% | — | — | |
| Q2 2015 | -18.9% | — | — | |
| Q1 2015 | +13.1% | — | — | |
| Q4 2014 | +5.7% | — | — | |
| Q3 2014 | -37.7% | — | — | |
| Q2 2014 | -14.3% | — | — | |
| Q1 2014 | +5.1% | — | — | |
| Q4 2013 | +4.4% | — | — | |
| Q3 2013 | -0.2% | — | — | |
| Q2 2013 | -2.2% | — | — | |
| Q1 2013 | +3.3% | — | — | |
| Q4 2012 | -2.7% | — | — | |
| Q3 2012 | +8.8% | — | — | |
| Q4 2011 | +6.6% | — | — | |
| Q2 2012 | -12.2% | — | — | |
| Q1 2012 | +2.2% | — | — | |
| Q3 2011 | -0.4% | — | — | |
| Q2 2011 | -2.6% | — | — | |
| Q1 2011 | +0.3% | — | — | |
| Q4 2010 | +1.1% | — | — | |
| Q3 2010 | -7.9% | — | — | |
| Q2 2010 | -13.4% | — | — | |
| Q1 2009 | -6.8% | — | — | |
| Q1 2010 | +5.7% | — | — | |
| Q4 2007 | -0.3% | — | — | |
| Q4 2009 | -0.3% | — | — | |
| Q4 2008 | -0.3% | — | — | |
| Q3 2008 | +2.4% | — | — | |
| Q3 2009 | +2.4% | — | — | |
| Q2 2009 | -1.7% | — | — | |
| Q2 2008 | -1.7% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro